25K fundamentals
An in-depth look to KARYOPHARM THERAP.DL-0001 operating, investing, and financing activities
25K free cash flow for Q4 23 is -16.84 M EUR. For 2023, 25K free cash flow was -84.01 M EUR and operating cash flow was -84.01 M EUR.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM